http://www.fda.gov/medical-devices/medical-device-recalls/american-contract-systems-recalls-covid-test-kits-nonsterile-and-clean-catch-urine-kits-risk-false

Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvanted
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-emergency-use-novavax-covid-19-vaccine-adjuvanted

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-propofol-injectable-emulsion-usp-containing

FDA Warns Four Companies for Selling Tainted Honey-based Products with Hidden Active Drug Ingredients
http://www.fda.gov/news-events/press-announcements/fda-warns-four-companies-selling-tainted-honey-based-products-hidden-active-drug-ingredients

FDA Infant Formula Update: July 8, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-july-8-2022

FDA Roundup: July 8, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-july-8-2022

FDA Developing New Framework for Continued, Expanded Access to Infant Formula Options for U.S. Parents and Caregivers
http://www.fda.gov/news-events/press-announcements/fda-developing-new-framework-continued-expanded-access-infant-formula-options-us-parents-and

Coronavirus (COVID-19) Update: FDA Authorizes Pharmacists to Prescribe Paxlovid with Certain Limitations
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pharmacists-prescribe-paxlovid-certain-limitations

FDA Infant Formula Update: July 6, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-july-6-2022

http://www.fda.gov/medical-devices/medical-device-recalls/getinge-usa-sales-inc-recalls-flow-c-and-flow-e-anesthesia-systems-cracked-or-broken-suction-system